Charles Daniel Myers, Jr.

Co-Founder at Alimera Sciences Inc.

Charles Daniel Myers, Jr.

Charles Daniel Myers, Jr.

Co-Founder at Alimera Sciences Inc.

Overview
Career Highlights

Alimera Sciences Inc.
Novartis AG
Novartis Ophthalmics, Inc.

RelSci Relationships

1389

Number of Boards

8

Birthday

04/1954

Age

65

Contact Data
Trying to get in touch with Charles Daniel Myers, Jr.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Charles Daniel Myers, Jr. likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chief Financial Officer & Vice President, Finance at Carticept Medical, Inc.

Relationship likelihood: Strong

Partner at Domain Associates LLC

Relationship likelihood: Strong

Co-Founder at Alimera Sciences Inc.

Relationship likelihood: Strong

President & Chief Executive Officer at Alimera Sciences Inc.

Relationship likelihood: Strong

Founder at Healthquest Capital Management Co. Llc

Relationship likelihood: Strong

Former Vice President, Strategic Planning at Allergan, Inc.

Relationship likelihood: Strong

Managing Partner at Polaris Partners

Relationship likelihood: Strong

Co-Founder at Alimera Sciences Inc.

Relationship likelihood: Strong

President, Director & Chief Executive Officer at Collexis Holdings, Inc.

Relationship likelihood: Strong

Professional at VR Management LLC

Relationship likelihood: Strong

Paths to Charles Daniel Myers, Jr.
Potential Connections via
Relationship Science
You
Charles Daniel Myers, Jr.
Co-Founder at Alimera Sciences Inc.
Education
B.S. in Industrial Management
Class of 1976

The Georgia Institute of Technology is a public research university in Atlanta, Georgia, in the United States. It is a part of the University System of Georgia and has satellite campuses in Savannah, Georgia; Metz, France; Athlone, Ireland; Shanghai, China; and Singapore. The educational institution was founded in 1885 as the Georgia School of Technology as part of Reconstruction plans to build an industrial economy in the post-Civil War Southern United States. Initially, it offered only a degree in mechanical engineering. By 1901, its curriculum had expanded to include electrical, civil, and chemical engineering. In 1948, the school changed its name to reflect its evolution from a trade school to a larger and more capable technical institute and research university. Today, Georgia Tech is organized into six colleges and contains about 31 departments/units, with emphasis on science and technology. It is well recognized for its degree programs in engineering, computing, business administration, the sciences, architecture, and liberal arts.

Career History
Co-Founder
2003 - Current

Alimera Sciences, Inc. engages in the research and development of biopharmaceutical products. It operates through the U.S. and International geographic segments. The firm focuses on the development of ophthalmic pharmaceuticals for the treatment of diabetic macular edema, wet and dry age-related macular degeneration, and retinal vein occlusion. Its products include ILUVIEN and NADPH Oxidase Inhibitors. The company was founded by Daniel C. Myers and David R. Holland on June 4, 2003 and is headquartered in Alpharetta, GA.

Founding Member
1997 - ?

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following four segments: Innovative Medicines, Alcon, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Alcon segment researches, develops, manufactures, distributes and sells eye care devices and vision care. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Founder
1991 - 2003

Novartis Ophthalmics, Inc. was a producer of pharmaceuticals, eye care and generic drugs. The company was headquartered in Duluth, GA.

Boards & Committees
Director
Current

National BioScience Corp., part of Polifenoles Naturales, is an American company located in Chester, NY. The firm develops products from botanicals. It was acquired by Polifenoles Naturales on 29 Jan 07.

Director
Current
Director
Prior

National Society to Prevent Blindness operates as an eye health and safety organization. It offers services for amblyopia, AMD, cataract, central retinal vein occlusion, colour blindness, conjunctivitis, diabetic eye disease and macular enema, dry eye, floaters, glaucoma, refractive eye, retinal tears and detachments, retinitis pigments and strabismus. The company was founded in 1908 and is headquartered in Chicago, IL.

Transactions
Details Hidden

Alimera Sciences Inc. raised money in a private placement transaction

Details Hidden

Alimera Sciences Inc. raised money in a private placement transaction

Details Hidden

Alimera Sciences Inc. raised money in a private placement transaction

Investments
Details Hidden

Alimera Sciences, Inc. engages in the research and development of biopharmaceutical products. It operates through the U.S. and International geographic segments. The firm focuses on the development of ophthalmic pharmaceuticals for the treatment of diabetic macular edema, wet and dry age-related macular degeneration, and retinal vein occlusion. Its products include ILUVIEN and NADPH Oxidase Inhibitors. The company was founded by Daniel C. Myers and David R. Holland on June 4, 2003 and is headquartered in Alpharetta, GA.

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Charles Daniel Myers, Jr.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Charles Daniel Myers, Jr.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Charles Daniel Myers, Jr..